The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma.

by S Di Matteo, L Nevi, D Costantini, D Overi, G Carpino, S Safarikia, F Giulitti, C Napoletano, E Manzi, A M De Rose, F Melandro, M Bragazzi, P B Berloco, F Giuliante, G Grazi, A Giorgi, V Cardinale, L Adorini, E Gaudio, D Alvaro
Published 2019-01-01